Could crowd funding be a solution to the financing struggles of young biotech companies in the early stages of drug development? Clive Cookson talks to Andrew Ward about the benefits and pitfalls of this new model for financing medical science.

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.